| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gillen Robert | Director | 1744 S. VAL VISTA DRIVE,, STE. 213, MESA | /s/ Robert D. Gillen | 25 Feb 2026 | 0001534562 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IVDA | Options (Right to Buy) | Disposed to Issuer | $0 | +100,000 | +350% | $0.000000 | 128,599 | 29 Dec 2025 | Common Stock | 100,000 | $0.8200 | Direct | |
| transaction | IVDA | Options (Right to Buy) | Award | $0 | +100,000 | +350% | $0.000000 | 128,599 | 23 Feb 2026 | Common Stock | 100,000 | $0.2900 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |